Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor beta variable 2 (TRBV2) is a segment of the variable domain of the β chain of the T cell receptor, essential for antigen specificity and adaptive immune function[1]. TRBV2 is part of the T cell receptor (TCR) complex expressed on αβ T lymphocytes, which recognize peptides presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells. Upon antigen binding, TCRs—via their variable domains like TRBV2—initiate intracellular signaling through the CD3 complex, activating pathways such as MAPK, calcium, and NF-κB, which control T cell proliferation, differentiation, and effector functions[1]. The diversity of the TRBV segments is generated through V(D)J recombination during thymic development, enabling recognition of a vast array of antigens[1][2]. Abnormalities or specific TRBV2 usage can be associated with certain cancers, infections, or autoimmune conditions. In therapeutic contexts, T cell receptor diversity can serve as a biomarker for immune reconstitution or clonal expansion, but targeting specific TCR Vβ segments carries a risk of immune misdirection or excessive activation[1].
Antigen recognition for T cell activation; Triggering intracellular signaling via interaction with peptide-major histocompatibility (pMH) complexes and CD3 co-receptors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor beta variable 2 (TRBV2).